These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 12908544)
1. Driving the cell cycle to cancer. Malumbres M; Hunt SL; Sotillo R; Martín J; Odajima J; Martín A; Dubus P; Ortega S; Barbacid M Adv Exp Med Biol; 2003; 532():1-11. PubMed ID: 12908544 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
3. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914 [TBL] [Abstract][Full Text] [Related]
4. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929 [TBL] [Abstract][Full Text] [Related]
5. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs. Risal S; Adhikari D; Liu K Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893 [TBL] [Abstract][Full Text] [Related]
7. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice. Hampl A; Pacherník J; Dvorák P Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192 [TBL] [Abstract][Full Text] [Related]
8. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours. Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177 [TBL] [Abstract][Full Text] [Related]
9. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A. Kim DM; Yang K; Yang BS Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383 [TBL] [Abstract][Full Text] [Related]
12. Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1. Matushansky I; Radparvar F; Skoultchi AI Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14317-22. PubMed ID: 11114185 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation. Chen B; Pollard JW Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329 [TBL] [Abstract][Full Text] [Related]
15. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Mettus RV; Rane SG Oncogene; 2003 Nov; 22(52):8413-21. PubMed ID: 14627982 [TBL] [Abstract][Full Text] [Related]
17. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Meng LH; Zhang H; Hayward L; Takemura H; Shao RG; Pommier Y Cancer Res; 2004 Dec; 64(24):9086-92. PubMed ID: 15604277 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]